Saba wants three seats on the Baillie Gifford US Growth board. Will it get one?
Saba has put three of its people up for the board of Baillie Gifford US Growth. The other shareholders decide on 23 October.
What happened
On the board of Baillie Gifford US Growth Trust called its annual meeting for and asked shareholders to vote against three Saba candidates for the board.
On Saba Capital asked Baillie Gifford US Growth Trust (BG US Growth) to put three of its people up for the board: Jason Chen, Thomas McGlade and James Waterlow. The request came through a nominee company and is for the trust’s annual meeting. The board told shareholders to take no action.
The annual meeting is at 1pm on in London. The board is unanimously against Saba’s three resolutions. It says it offered Saba a cash exit several times at asset value less the cost of selling holdings, about 99.75% of asset value, with Baillie Gifford paying the other costs. Saba turned it down each time.
The board says shareholders have voted Saba down before. If the three resolutions fail, it will go back to Saba about a cash exit close to asset value, open to Saba and any other shareholder who wants to leave.
Saba owns about 29% of the £1bn trust. Tim Campbell, chief executive of Baillie Gifford, told The Herald that a Saba win would be sad for the trust’s other holders. He said most of them are retail savers, many do not vote, and funds that tend to follow Saba are also on the register.
Sources: BG US Growth (2), The Herald
The Pattern
We looked for cases where an activist with a large stake in an investment trust, but less than half, put its own people up for the board at a set meeting, and the board and the manager were against. We found ten, nine of them Saba’s, from 2015 to 2026. The activist got seats in two.
Show the other 8 cases
The Read
History is against Saba: the activist got seats in 2 of 10 cases. The ten are less than they look. Seven were one round of meetings Saba called in early 2025, and it lost all seven, including a first try at this trust in , where 65.6% voted against it.
The two wins share a feature. Both came at annual meetings, where sitting directors must stand again, and all eight losses came at meetings Saba called itself. The vote is an annual meeting. That rests on two cases, so it moves our estimate but does not replace History.
Outside Saba, holders voted almost as one against it in every loss where the trusts gave the figure. The one win came after three other US funds joined Saba, together over 40% of the shares. Baillie Gifford’s chief executive says funds of that kind are on the BG US Growth register too.
The trust will publish the vote on the London Stock Exchange news service on . A deal before the meeting, as at Alliance Trust in 2015, would settle the seat question early.
Disclaimer
Hunch works only from sources that are publicly available, and publishes on the basis of analysis of that material. We do not form an editorial opinion or take sides, we give a simpler and wider view of news that already exists. If information in a source we used was inaccurate, distorted, or later disputed but had already entered our analysis, Hunch accepts no liability for that. Predictions are not advice. Phase 1 markets use Hunch Points, not money.
Published by Hunch under the Editorial Code. Complaints and corrections: /contact/.
